MoonLake Immunotherapeutics (MLTX)

MoonLake Immunotherapeutics (MLTX) is a healthcare company (biotechnology) based in Switzerland. The share price is $11.25, down 4.09% on the day, which values the company at $957.45M. Price as of 18 Nov 2026, 11:56 UTC, from Yahoo Finance.

Key facts

Share price
$11.25−4.09% today
Market value
$957.45M
200-week average
$35.8669% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

MoonLake Immunotherapeutics in more detail

MLTX trades at -3.3× next year's expected earnings. It sits 69% below its 200-week average of $35.86.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

MoonLake Immunotherapeutics (MLTX): questions and answers

What is MoonLake Immunotherapeutics's market cap?

MoonLake Immunotherapeutics is valued at $957.45M at a share price of $11.25.

Is MLTX above its 200-week moving average?

No. MLTX is 68.6% below its 200-week average of $35.86. Long-term investors watch that line because strong companies rarely trade below it for long.

Does MLTX pay a dividend?

MoonLake Immunotherapeutics does not currently pay a regular dividend.

Cite this page

Funkfolio, “MoonLake Immunotherapeutics (MLTX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/MLTX

Underlying data: Yahoo Finance; company filings with the SEC.